Global health boost as new vaccine SKYTyphoid gains WHO prequalification

SK bioscience and the International Vaccine Institute (IVI) announced today that the typhoid conjugate vaccine developed by SK bioscience with technology transfer from IVI has achieved the World Health Organization prequalification (PQ), which paves the way for public procurement of the vaccine by UN organizations and gives a boost to the global TCV supply.

Men face sharper brain aging from obesity and heart risks

Obesity and cardiovascular risk factors accelerate brain volume loss, with males experiencing earlier and more significant impacts, highlighting the importance of early interventions to prevent

December 2, 2024

Health Canada approves FYB201/Ranopto® (Ranibizumab), a biosimilar to Lucentis® – Biotech Investments

EQS-News: Formycon AG / Key word(s): Regulatory Approval Health Canada approves FYB201/Ranopto® (Ranibizumab), a biosimilar to Lucentis® 07.12.2023 / 07:30 CET/CEST The issuer is solely

December 8, 2023

Late Tenecteplase Not Beneficial for Stroke Patients With LVOs

PHOENIX — Selected stroke patients did not benefit clinically from having the window of tenecteplase therapy extended beyond the first few hours of stroke onset,

February 10, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.